ZYXI - Zynex, Inc.
NASDAQ
->
Healthcare
->
Medical Distribution
Englewood,
United States
Type: Equity
ZYXI price evolution
ZYXI
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $31.3 | $33.27 | $44.99 | $42.93 |
| Short term investments | $9.92 | |||
| Net receivables | $23.59 | $25.44 | $26.84 | $33.29 |
| Inventory | $15.39 | $15.48 | $13.11 | $14.19 |
| Total current assets | $74.11 | $77.99 | $87.86 | $102.92 |
| Long term investments | ||||
| Property, plant & equipment | $15.22 | $15.63 | $16.22 | $16.27 |
| Goodwill & intangible assets | $28.11 | $28.33 | $28.56 | $28.79 |
| Total noncurrent assets | $47.8 | $48.24 | $49.05 | $48.51 |
| Total investments | $9.92 | |||
| Total assets | $121.92 | $126.22 | $136.9 | $151.43 |
| Current liabilities | ||||
| Accounts payable | $7.88 | $10.32 | $8.43 | $8.05 |
| Deferred revenue | ||||
| Short long term debt | $4.11 | $4.06 | $3.92 | $3.28 |
| Total current liabilities | $18.24 | $21.75 | $18.53 | $19.84 |
| Long term debt | $70.86 | $71.37 | $72.24 | $73 |
| Total noncurrent liabilities | $70.86 | $71.37 | $72.24 | $73 |
| Total debt | $74.97 | $75.43 | $76.17 | $76.29 |
| Total liabilities | $89.1 | $93.13 | $90.78 | $92.85 |
| Shareholders' equity | ||||
| Retained earnings | $28.01 | $26.79 | $26.78 | $25.57 |
| Other shareholder equity | ||||
| Total shareholder equity | $32.82 | $33.1 | $46.13 | $58.58 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $44.99 | $20.73 | $43.2 | $39.52 |
| Short term investments | ||||
| Net receivables | $26.84 | $35.06 | $28.63 | $13.84 |
| Inventory | $13.11 | $13.48 | $10.76 | $8.63 |
| Total current assets | $87.86 | $69.56 | $82.69 | $63.02 |
| Long term investments | ||||
| Property, plant & equipment | $16.22 | $15.29 | $18.91 | $8.24 |
| Goodwill & intangible assets | $28.56 | $29.47 | $30.38 | |
| Total noncurrent assets | $49.05 | $46.91 | $50.59 | $9.15 |
| Total investments | ||||
| Total assets | $136.9 | $116.47 | $133.27 | $72.17 |
| Current liabilities | ||||
| Accounts payable | $8.43 | $5.62 | $8.37 | $4.72 |
| Deferred revenue | ||||
| Short long term debt | $3.92 | $7.94 | $8.31 | $2.13 |
| Total current liabilities | $18.53 | $21.09 | $22.87 | $10.12 |
| Long term debt | $72.24 | $19.02 | $26.78 | $5.2 |
| Total noncurrent liabilities | $72.24 | $29.02 | $36.48 | $5.2 |
| Total debt | $76.17 | $26.96 | $35.09 | $7.33 |
| Total liabilities | $90.78 | $50.11 | $59.35 | $15.32 |
| Shareholders' equity | ||||
| Retained earnings | $26.78 | $17.05 | $23.43 | |
| Other shareholder equity | ||||
| Total shareholder equity | $46.13 | $66.36 | $73.92 | $56.85 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $49.88 | $46.53 | $47.28 | $49.91 |
| Cost of revenue | $9.97 | $9.3 | $10.27 | $9.55 |
| Gross Profit | $39.91 | $37.23 | $37.01 | $40.36 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $37.69 | $36.71 | $34.72 | $34.88 |
| Total operating expenses | $37.69 | $36.71 | $34.72 | $34.88 |
| Operating income | $2.23 | $0.53 | $2.3 | $5.49 |
| Income from continuing operations | ||||
| EBIT | $2.25 | $0.53 | $2.3 | $5.28 |
| Income tax expense | $0.4 | $0 | $0.72 | $1.36 |
| Interest expense | $0.63 | $0.51 | $0.37 | $0.33 |
| Net income | ||||
| Net income | $1.22 | $0.01 | $1.22 | $3.59 |
| Income (for common shares) | $1.22 | $0.01 | $1.22 | $3.59 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $184.32 | $158.17 | $130.3 | $80.12 |
| Cost of revenue | $38.37 | $32.01 | $27.32 | $17.42 |
| Gross Profit | $145.96 | $126.16 | $102.98 | $62.7 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $135.18 | $103.22 | $80.61 | $52.46 |
| Total operating expenses | $135.18 | $103.22 | $80.61 | $52.46 |
| Operating income | $10.78 | $22.94 | $22.37 | $10.25 |
| Income from continuing operations | ||||
| EBIT | $13.67 | $22.64 | $22.37 | $10.17 |
| Income tax expense | $2.85 | $5.15 | $5.17 | $1.08 |
| Interest expense | $1.09 | $0.44 | $0.1 | $0.02 |
| Net income | ||||
| Net income | $9.73 | $17.05 | $17.1 | $9.07 |
| Income (for common shares) | $9.73 | $17.05 | $17.1 | $9.07 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Net income | $1.22 | $0.01 | $1.22 | $3.59 |
| Operating activities | ||||
| Depreciation | $0.88 | $0.91 | $1.49 | $1.86 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.84 | $0.73 | $0.68 | $0.65 |
| Total cash flows from operations | $1.13 | $2.07 | $6.19 | $8.89 |
| Investing activities | ||||
| Capital expenditures | -$0.14 | -$0.15 | -$0.58 | -$0.2 |
| Investments | $10 | -$9.81 | ||
| Total cash flows from investing | -$0.14 | -$0.15 | $9.42 | -$10.01 |
| Financing activities | ||||
| Dividends paid | -$0 | -$0 | ||
| Sale and purchase of stock | -$2.35 | -$13.27 | -$13.47 | -$14.93 |
| Net borrowings | -$0.03 | -$0.12 | -$0.03 | -$0.04 |
| Total cash flows from financing | -$2.96 | -$13.63 | -$13.55 | -$15.12 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$1.97 | -$11.72 | $2.06 | -$16.23 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $9.73 | $17.05 | $17.1 | $9.07 |
| Operating activities | ||||
| Depreciation | $5.12 | $3.93 | $3.68 | $1.57 |
| Business acquisitions & disposals | -$16 | |||
| Stock-based compensation | $2.3 | $2.34 | $1.63 | $2.68 |
| Total cash flows from operations | $17.76 | $13.75 | $6.95 | $0.82 |
| Investing activities | ||||
| Capital expenditures | -$1.16 | -$0.42 | -$0.61 | -$0.98 |
| Investments | $0.19 | |||
| Total cash flows from investing | -$0.97 | -$0.42 | -$16.61 | -$0.98 |
| Financing activities | ||||
| Dividends paid | -$0 | -$3.61 | -$0 | |
| Sale and purchase of stock | -$37.84 | -$26.38 | -$2.51 | $25.77 |
| Net borrowings | $46.22 | -$5.45 | $15.84 | -$0.06 |
| Total cash flows from financing | $7.64 | -$35.8 | $13.1 | $25.3 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $24.43 | -$22.47 | $3.44 | $25.13 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $193.61M |
|---|---|
| EBITDA | $15.48M |
| EBIT | $10.34M |
| Net Income | $6.04M |
| Revenue Q/Q | 10.97% |
| Revenue Y/Y | 9.11% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | 4.50% |
| ROE | 14.15% |
| Debt/Equity | 1.97 |
|---|---|
| Net debt/EBITDA | 3.73 |
| Current ratio | 4.06 |
| Quick ratio | 3.22 |